ONS/ONCC
CHEMOTHERAPY/IMMUNOTHERAPY
LESSON 14: ADMINISTRATION OF
DRUGS 100% CORRECT
Verification of Treatment as Planned - ANSWER -vascular access device appropriate
for treatment plan
-will patient adhere to plan
-is the treatment plan appropriate for patient
-do additional referals need to be made for treatment
-is there evidenced based rationale for treatment
-is the drug a vesicant and are there safety precautions in place
-is the drug a cumulative lifetime dose limit and is there tracking in place
Patient education - ANSWER -assess pt's readiness to learn, health literacy, preferred
method of learning, barriers to learning
-provide pt with info needed in the way that they need to be as informed about treatment
plan as possible
-verify pts/any caregivers or significant others can verbalize understanding of info
Considerations when scrutinizing the treatment plan - ANSWER -right tx plan for
disease, pt, and stage
-goal of tx stated
-drugs, frequence, dose stated
-appropriate premeds
-appropriate hydration
-pt venous access options
-to avoid delays/maintain dose intensity, what potential side effects should be
anticipated & how can these be proactively addressed
-dose-density of therapy/does it apply
-is dose intensity appropriate
5. Select a vein large enough to accommodate the catheter.
IV sites to avoid.
1. Areas of flexion, especially the antecubital area. (NO CHEMO TO ANTECUBITAL)
2. Veins previously injured by infiltration or phlebitis.
3. Veins of an affected extremity: mastectomy, dialysis access.
4. Veins of an extremity affected by stroke or neurologic trauma.
5. Veins in the lower extremities and sclerosed or irritated veins.
6. Avoid previous venipuncture sites, areas of inflammation or bruising.
CHEMOTHERAPY/IMMUNOTHERAPY
LESSON 14: ADMINISTRATION OF
DRUGS 100% CORRECT
Verification of Treatment as Planned - ANSWER -vascular access device appropriate
for treatment plan
-will patient adhere to plan
-is the treatment plan appropriate for patient
-do additional referals need to be made for treatment
-is there evidenced based rationale for treatment
-is the drug a vesicant and are there safety precautions in place
-is the drug a cumulative lifetime dose limit and is there tracking in place
Patient education - ANSWER -assess pt's readiness to learn, health literacy, preferred
method of learning, barriers to learning
-provide pt with info needed in the way that they need to be as informed about treatment
plan as possible
-verify pts/any caregivers or significant others can verbalize understanding of info
Considerations when scrutinizing the treatment plan - ANSWER -right tx plan for
disease, pt, and stage
-goal of tx stated
-drugs, frequence, dose stated
-appropriate premeds
-appropriate hydration
-pt venous access options
-to avoid delays/maintain dose intensity, what potential side effects should be
anticipated & how can these be proactively addressed
-dose-density of therapy/does it apply
-is dose intensity appropriate
5. Select a vein large enough to accommodate the catheter.
IV sites to avoid.
1. Areas of flexion, especially the antecubital area. (NO CHEMO TO ANTECUBITAL)
2. Veins previously injured by infiltration or phlebitis.
3. Veins of an affected extremity: mastectomy, dialysis access.
4. Veins of an extremity affected by stroke or neurologic trauma.
5. Veins in the lower extremities and sclerosed or irritated veins.
6. Avoid previous venipuncture sites, areas of inflammation or bruising.
